Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.

Death Investigation in Woodstock
MURC: Coming Soon to Ingersoll!
Candidate Information Session Coming Up
EZT Remembers Former Ward 3 Councillor
SWPH Issues Cold Weather Alert
UPDATE: Strong Winds Continue this Morning
Woodstock Resident Charged with Speeding
Interview with the Mayor - March 16th, 2026
Woodstock Driver Charged in Brant County
PJHL Playoff Recap - March 13th to March 15th
March Break Safety Tips from Oxford OPP
Oxford-Elgin Rainbow Research Project Underway
OPP: Plan Ahead Before St. Paddy's Day Festivities
Another Friday the 13th in Port Dover Today
Hansen Parents Visit Artemis II Explorers Club at IDCI
East Oxford Parents Respond to AARC Announcement
Strong Winds Expected in Oxford
WPS Charge Two in Firearms Incident
Food Rescue Hub Receives $50,000
Interview with the Warden - March 12th, 2026
Comments
Add a comment